90 likes | 198 Views
Institute of Life Science Phase 2. Project Overview School Staff Assembly 10 th June 2009. Vision. To create a sustainable venture that advances medical science through research and innovation for the benefit of…
E N D
Institute of Life Science Phase 2 Project Overview School Staff Assembly 10th June 2009
Vision • To create a sustainable venture that advances medical science through research and innovation for the benefit of… • the knowledge economy in Wales by linking scientific and medical advancement to wealth creation and… • human health through improved prevention and treatment of disease
Project Context • A Partnership between the School of Medicine, ABMU NHS Trust, WAG Department of Health and the European Union (WEFO) • Lisbon Agenda (Growth and Jobs) • Convergence Operational Programme • R&D / Innovation Framework • Wales Science Policy • Wales Spatial Plan • Other WAG/UK/Local Strategies
Project Purpose • Co-funded by the European Regional Development Fund, the purpose of ILS Phase 2 is to support the development of the regional life science cluster through; • Assisting enterprises in the Convergence region to innovate and grow • Strengthening the regional R&D infrastructure • Establishing research collaborations between academia and local industry • Attraction of inward investment
Project Components • Translational Medicine; taking innovations from bench to bedside • Clinical Research Facility (bedded unit) • Imaging Centre • Health Informatics Research • Business Development Facilities • Technology Transfer Team • CNH Tenant Project • + ILS(1)
Project Funding and Costs • WEFO: £12.85m (cash) • WAG: £8.5m (cash) • ABMU NHS Trust: £1m (in-kind) – land • Swansea University: £2.2m (in-kind) – Staff Time (sheets) • £2.8m (in-kind) – Overheads • Project Income £1.5m (cash) • Building £16m • Equipment £3m • Tech Transfer £1.2m • CRF £2.3m • Income • Costs
Project Outputs/Outcomes • 300 Enterprises/Individuals Assisted • 30 Collaborative Projects • 400 Jobs Created • 10 Enterprises Created • £20m Profit Benefit • £20m Investment Induced • 15 New products/processes/services registered • 175 New products/processes/services launched
Institute of Life Science Phase 2 Project Overview Thank You